Kymera Therapeutics, Inc. (KYMR) Insider Trading -- Recent Executive & Director Transactions

27 insiders reported 439 Form 4 transactions for Kymera Therapeutics, Inc. (KYMR) over the past 18 months (most recent 2026-09-04). Recent activity: Adams Brian (Chief Legal Officer) Sell 3,025 shares, Adams Brian (Chief Legal Officer) Sell 2,137 shares, Adams Brian (Chief Legal Officer) Sell 1,209 shares, Rooney Terence (Chief Medical Officer) Buy 38,000 shares, Mainolfi Nello (Chief Executive Officer) Buy 50,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-04Adams BrianChief Legal OfficerSell3,025$353,350
2026-09-04Adams BrianChief Legal OfficerSell2,137$251,247
2026-09-04Adams BrianChief Legal OfficerSell1,209$139,700
2026-07-27Rooney TerenceChief Medical OfficerBuy38,000$0
2026-07-07Mainolfi NelloChief Executive OfficerBuy50,000$104,000
2026-07-07Mainolfi NelloChief Executive OfficerSell50,000$6.0M
2026-07-02Mainolfi NelloChief Executive OfficerSell1,883$212,411
2026-07-02Jacobs Bruce N.Chief Financial OfficerBuy61,378$327,145
2026-07-02Mainolfi NelloChief Executive OfficerBuy80,000$166,400
2026-07-02Goodman NoahChief Business OfficerSell3,389$387,329
2026-07-02Booth BruceDirectorSell14,798$1.6M
2026-07-02Jacobs Bruce N.Chief Financial OfficerSell1,500$165,810
2026-07-02Booth BruceDirectorSell5,549$586,973
2026-07-02Booth BruceDirectorSell19,419$2.1M
2026-07-02Jacobs Bruce N.Chief Financial OfficerSell1,700$189,664
2026-07-02Mainolfi NelloChief Executive OfficerSell6,626$755,204
2026-07-02Booth BruceDirectorSell10,848$1.2M
2026-07-02Jacobs Bruce N.Chief Financial OfficerSell1,100$124,067
2026-07-02Mainolfi NelloChief Executive OfficerSell24,105$2.8M
2026-07-02Booth BruceDirectorSell7,968$874,488
2026-07-02Jacobs Bruce N.Chief Financial OfficerSell4,110$469,311
2026-07-02Mainolfi NelloChief Executive OfficerSell44,050$5.1M
2026-07-02Booth BruceDirectorSell7,723$854,704
2026-07-02Jacobs Bruce N.Chief Financial OfficerSell51,375$5.9M
2026-07-02Mainolfi NelloChief Executive OfficerSell3,336$388,841

来源:SEC Form 4 申报文件 · 截至 2026-09-04